Markets:

Overview

News

Currencies

International

Treasuries

Larimar Therapeutics, Inc. - Common Stock (NQ:LRMR)

3.695 +0.885 (+31.49%)

Streaming Delayed Price Updated: 1:06 PM EST, Feb 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Larimar Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Tuesday's session: top gainers and losers ↗

Today 12:30 EST

Via Chartmill

Larimar Therapeutics (LRMR) Surges On FDA Breakthrough Therapy Designation ↗

Today 12:12 EST

Larimar Therapeutics Inc (NASDAQ: LRMR) shares are trading sharply higher Tuesday after the company said the U.S. Food and Drug Administration granted Breakthrough Therapy Designation to its...

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

Today 10:30 EST

Via Chartmill

Why Did Larimar Therapeutics’ Stock Surge Over 30% Pre-Market Today? ↗

Today 9:07 EST

The FDA has granted Breakthrough Therapy Designation to Larimar’s frataxin protein replacement therapy, nomlabofusp.

Via Stocktwits

Larimar Therapeutics Stock Slumps Pre-market Over High Anaphylaxis Rate In Drug Study ↗

September 29, 2025

Via Stocktwits

Which stocks are moving before the opening bell on Tuesday? ↗

Today 8:30 EST

Via Chartmill

What's going on in today's after hours session ↗

November 17, 2025

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR

October 30, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

October 29, 2025

From Schall Law

Via GlobeNewswire

The Best AI for Picking Stocks, Ranked by Performance ↗

October 22, 2025

AI can pick stocks, but that doesn't mean it will do a good job. Here's a look at how the choices made by 7 leading AIs performed over a 90-day time period.

Via MarketBeat

Topics Artificial Intelligence ETFs

Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR

October 22, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – LRMR

October 15, 2025

From DJS Law Group

Via Business Wire

LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

October 15, 2025

From The Schall Law Firm

Via Business Wire

Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

October 06, 2025

Via Benzinga

Which stocks are moving on Wednesday? ↗

October 01, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 01, 2025

Via Benzinga

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

October 01, 2025

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

September 29, 2025

Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 29, 2025

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands at $5.5 million. Zura Bio (NASDAQ: ZURA) stock moved upwards by 42.94% to $3.44....

Via Benzinga

Top stock movements in today's session. ↗

September 29, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

Larimar Therapeutics Stock Falls After Patients Report Allergic Reaction In Pivotal Study ↗

September 29, 2025

Larimar Therapeutics Inc. (NASDAQ: LRMR) is trading lower on Monday after the company released data from the ongoing long-term open-label (OL) study evaluating daily subcutaneous 25 mg and 50 mg...

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

September 29, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

September 29, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 29, 2025

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The market value of their outstanding shares is at $10.5 million.

Via Benzinga

Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket ↗

September 29, 2025

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its...

Via Benzinga

Larimar Beats Q2 Loss Estimates ↗

August 14, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 29, 2025

Via Benzinga

What's going on in today's after hours session ↗

July 29, 2025

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

This MicroStrategy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

January 29, 2025

Via Benzinga

What's Going On With Larimar Therapeutics Stock On Tuesday? ↗

December 17, 2024

Larimar Therapeutics reports promising FXN level increases with 25 mg nomlabofusp, advancing towards dose escalation for Friedreich's Ataxia treatment.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.